21![Topic Suggestions….Contact: Pharmaceutical Services Division Health and Community Services P.O. Box 8700 St. John’s, NL A1B 4J6 Tel: [removed]Fax: [removed] Topic Suggestions….Contact: Pharmaceutical Services Division Health and Community Services P.O. Box 8700 St. John’s, NL A1B 4J6 Tel: [removed]Fax: [removed]](https://www.pdfsearch.io/img/0c5546b6a6caa0115456bb48fcf9b533.jpg) | Add to Reading ListSource URL: www.health.gov.nl.caLanguage: English - Date: 2010-07-08 14:09:58
|
---|
22![2014 Exchange Step Therapy Criteria Last Modified: [removed]General Criteria: 2014 Exchange Step Therapy Criteria Last Modified: [removed]General Criteria: ](https://www.pdfsearch.io/img/b6a60bec1d819268012e22d22d2d9d2c.jpg) | Add to Reading ListSource URL: www.pacificsource.comLanguage: English |
---|
23![Effexorâ (venlafaxine hydrochloride) Tablets only This product’s label may have been revised after this insert was used in production. For further product information and current Effexorâ (venlafaxine hydrochloride) Tablets only This product’s label may have been revised after this insert was used in production. For further product information and current](https://www.pdfsearch.io/img/92b70e5b94ff8717081d73dc5e942aa8.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-06-08 09:31:20
|
---|
24![SUPPLEMENTAL NEW DRUG APPLICATION – PEDIATRIC INDICATIONS BPCA SUMMARY REVIEW OFFICE OF CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS NDAs: 20-151 SUPPLEMENTAL NEW DRUG APPLICATION – PEDIATRIC INDICATIONS BPCA SUMMARY REVIEW OFFICE OF CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS NDAs: 20-151](https://www.pdfsearch.io/img/93fc829cd96c7d11da16390ea6996882.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-06-08 09:31:22
|
---|
25![2014 Exchange Step Therapy Criteria Last Modified: [removed]General Criteria: 2014 Exchange Step Therapy Criteria Last Modified: [removed]General Criteria: ](https://www.pdfsearch.io/img/71129f3161cf5e291526546db9ed087d.jpg) | Add to Reading ListSource URL: pacificsource.comLanguage: English |
---|
26![Serotonin and Norepinephrine Reuptake Inhibitors (SNRI) Step Therapy Program ® Cymbalta (duloxetine HCl delayed-release capsules) Desvenlafaxine extended-release tablets (brand product) ™ Serotonin and Norepinephrine Reuptake Inhibitors (SNRI) Step Therapy Program ® Cymbalta (duloxetine HCl delayed-release capsules) Desvenlafaxine extended-release tablets (brand product) ™](https://www.pdfsearch.io/img/ffe38527ca126edcdbaedb302b2dbdfc.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-02-27 10:19:32
|
---|
27![9 ‘” ~ Sample Written Request for Antidepressants ,,, ,r’ 9 ‘” ~ Sample Written Request for Antidepressants ,,, ,r’](https://www.pdfsearch.io/img/e63e2c903d70e5187a3eb9b1f53e56ad.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-09-25 04:40:57
|
---|
28![Pharmacy NewsCapsule - July/August 2009 Pharmacy NewsCapsule - July/August 2009](https://www.pdfsearch.io/img/108ed4b01ae067ea52ee4ad91e60a84a.jpg) | Add to Reading ListSource URL: www.dhs.wisconsin.govLanguage: English - Date: 2009-07-23 16:56:27
|
---|
29![Pristiq (desvenlafaxine succinate) tablet label Pristiq (desvenlafaxine succinate) tablet label](https://www.pdfsearch.io/img/ec641b28742ed05df01da3016ad78786.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-04-12 12:08:49
|
---|
30![Effexorâ (venlafaxine hydrochloride) Tablets only This product’s label may have been revised after this insert was used in production. For further product information and current Effexorâ (venlafaxine hydrochloride) Tablets only This product’s label may have been revised after this insert was used in production. For further product information and current](https://www.pdfsearch.io/img/21203c339a6af91a5a45edbe5f119325.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-08-20 09:51:00
|
---|